banner
Survivin inhibitor Sepantronium bromide, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ164

Survivin inhibitor Sepantronium bromide, Purity ≥98%

Synonym: 781661-94-7; Sepantronium bromide; YM155; YM-155; Ym 155; YM155 (Sepantronium Bromide); Survivin inhibitor

  • MDL: MFCD11983133
  • CAS Number: 781661-94-7
  • Compound CID: 11178236
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Sepantronium bromide, soluble in DMSO, water and ethanol, plays a crucial role in inhibiting cell death and regulating cell division. It targets Survivin (HeLa-SURP-luc, CHO-SV40-luc cells).
Molecular Weight
443.3
Molecular Formula
C20H19BrN4O3
Targets
Survivin (HeLa-SURP-luc, CHO-SV40-luc cells): 0.54 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 52 mg/mL (117.3 mM); Water: 85 mg/mL (191.75 mM); Ethanol: 6 mg/mL (13.53 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Sepantronium bromide can be utilized to study its role as a survivin inhibitor and its applications in promoting cancer cell apoptosis.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0